Literature DB >> 22238842

Barriers to metabolic care for adults with serious mental illness: provider perspectives.

Michael G McDonell1, Erin A Kaufman, Debra S Srebnik, Paul S Ciechanowski, Richard K Ries.   

Abstract

This study assessed barriers to metabolic care for persons with serious mental illness (SMI) by surveying experienced healthcare providers. Sixty-eight medical, mental health, and other stakeholders who care for patients with SMI attended a CME conference focused on medical management of SMI patients in 2007. They completed a 27-item survey assessing barriers to and systemic responsibility for metabolic care. The top three ranked barriers were: "separate mental health and primary care systems," "patient's lack of resources," and "[mental health] providers are not trained to do basic primary care." Results indicated that ratings of CMHC responsibility for SMI metabolic care (M = 5.2, SD = 1.5) were significantly lower than ratings of public health (M = 5.7, SD = 1.4), t(66) = 2.3, p = 0.027, and primary care providers (M = 6.3, SD = 1.1), t(67) = 4.7,p <0.001. Experienced providers identified a lack of integrated care and patient characteristics as important barriers to metabolic care and concluded that the primary care and public health systems are primarily responsible for metabolic treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22238842     DOI: 10.2190/PM.41.4.g

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  8 in total

1.  Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners.

Authors:  Kirsti Jakobs; Latoya Lautan; Peter Lucassen; Joost Janzing; Jan van Lieshout; Marion C J Biermans; Erik W M A Bischoff
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

2.  The Validity and Reliability Characteristics of the M-BACK Questionnaire to Assess the Barriers, Attitudes, Confidence, and Knowledge of Mental Health Staff Regarding Metabolic Health of Mental Health Service Users.

Authors:  Andrew Watkins; Simon Rosenbaum; Philip B Ward; Joanna Patching; Elizabeth Denney-Wilson; Jane Stein-Parbury
Journal:  Front Public Health       Date:  2017-12-11

3.  Effects of primary care clinician beliefs and perceived organizational facilitators on the delivery of preventive care to individuals with mental illnesses.

Authors:  Bobbi Jo H Yarborough; Scott P Stumbo; Nancy A Perrin; Ginger C Hanson; John Muench; Carla A Green
Journal:  BMC Fam Pract       Date:  2018-01-12       Impact factor: 2.497

4.  Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice.

Authors:  Kirsti M Jakobs; Anne Posthuma; Wim J C de Grauw; Bianca W M Schalk; Reinier P Akkermans; Peter Lucassen; Tjard Schermer; Willem J J Assendelft; Marion J C Biermans
Journal:  BMC Fam Pract       Date:  2020-07-29       Impact factor: 2.497

5.  Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs: a systematic review.

Authors:  Ruba Azfr Ali; Zahraa Jalal; Vibhu Paudyal
Journal:  BMC Psychiatry       Date:  2020-12-04       Impact factor: 3.630

6.  Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis.

Authors:  Pruntha Kanagasundaram; Jiwon Lee; Femin Prasad; Kenya A Costa-Dookhan; Laurie Hamel; Madeleine Gordon; Gary Remington; Margaret K Hahn; Sri Mahavir Agarwal
Journal:  Front Psychiatry       Date:  2021-03-17       Impact factor: 4.157

7.  Commentary.

Authors:  Joseph B Stoklosa
Journal:  J Neurosci Rural Pract       Date:  2012-09

Review 8.  The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review.

Authors:  L M Grünwald; C Duddy; R Byng; N Crellin; J Moncrieff
Journal:  BMC Psychiatry       Date:  2021-08-04       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.